Reaction

Haematotympanum reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 84 reports · 2 co-occurring drugs

As of the last recalculation, Haematotympanum appears in 84 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is IBRUTINIB (PRR 183.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ibrutinib35183.3183.4
Acalabrutinib485.885.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.